论文部分内容阅读
1商品名Hercetin2开发与上市厂商（美）Genentech公司研制并于1998年6月首次在美国上市。3药效分类免疫激动剂4药理本品是一种重组“人化”的单克隆抗体（rhuMAb），可与致癌基因HERZ编码的蛋白结合，本品可单独用于对化疗无效者或与紫杉醇合用作为转移性乳腺癌（MBC）的一线治
1 Name Hercetin2 Development and listing of manufacturers (the United States) Genentech company developed and in 1998 June for the first time in the United States. 3 Pharmacodynamic classification Immune agonist 4 Pharmacology This product is a recombinant “humanized” monoclonal antibody (rhuMAb), with the oncogene HERZ encoded protein binding, the product can be used alone for chemotherapy ineffective or with paclitaxel Combined as a first line treatment of metastatic breast cancer (MBC)